Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1206 | Late Breaking | ECE2022

The impact of gh treatment in turner syndrome

Hrisca Anamaria , Dumitru Teodora , Andrei Diana , Florescu Alexandru , Leustean Letitia , Rusu Cristina , Preda Cristina , Ungureanu Maria Christina

Introduction: The treatment with growth hormone (GH) plays an essential role in the Turner syndrome (TS) management. This study evaluated its efficacy in improving adult height (AH) and metabolic parameters.Material and methods: We retrospectively analysed auxological, biochemical, genetic and pharmacological parameters of 56 girls with confirmed TS. They were categorised according to their karyotype as X monosomy (62%), isochromosome (17%), X mosaicism ...

ea0050p333 | Obesity and Metabolism | SFEBES2017

Genes involved in zinc homeostasis are associated with metabolic syndrome and insulin resistance in Romanian and French populations

Ilie Mirela Diana , Haydar Sara , Vintila Madalina , Lautier Corinne , Normand Christophe , Gheorghiu Monica , Poiana Catalina , Badiu Corin , Grigorescu Florin

Introduction: Zinc homeostasis is involved in numerous physiological and pathological conditions, ranging from type 1 and type 2 diabetes to memory impairment and cancer, and is determined by at least 28 genes, including 24 SLC (Solute Carrier) family members and 4 MTs (Metallothioneins). To explore the potential role of zinc homeostasis in MetS (metabolic syndrome) and IR (insulin resistance), we investigated 28...

ea0050p333 | Obesity and Metabolism | SFEBES2017

Genes involved in zinc homeostasis are associated with metabolic syndrome and insulin resistance in Romanian and French populations

Ilie Mirela Diana , Haydar Sara , Vintila Madalina , Lautier Corinne , Normand Christophe , Gheorghiu Monica , Poiana Catalina , Badiu Corin , Grigorescu Florin

Introduction: Zinc homeostasis is involved in numerous physiological and pathological conditions, ranging from type 1 and type 2 diabetes to memory impairment and cancer, and is determined by at least 28 genes, including 24 SLC (Solute Carrier) family members and 4 MTs (Metallothioneins). To explore the potential role of zinc homeostasis in MetS (metabolic syndrome) and IR (insulin resistance), we investigated 28...

ea0090p215 | Thyroid | ECE2023

Nonfunctioning thyroid nodules in graves’ disease – do they harbor a higher risk of malignancy?

Salome Serranito Maria , Cunha Nelson , Abegao Matias Alexandra , Sabino Teresa , Martins Diana , Palha Ana , Matos Lurdes , Silva-Nunes Jose

Introduction: The prevalence of palpable thyroid nodules in Graves’ disease (GD) is approximately 15%. Cytopathologic interpretation in GD is challenging due to frequent cytomorphologic changes, namely after radioactive iodine (RAI) therapy. Some of the few published studies regarding fine-needle aspiration (FNA) in patients with GD, suggest an increased risk of malignancy of thyroid nodules arising in GD patients. However, the results are inconsistent, and there is no co...

ea0090ep1158 | Late Breaking | ECE2023

BRCA1/2 Negative Bilateral Metastasized Breast Cancer Following Ovarian Stimulation: A Case Report

Oliveira Torres Joao , Leao Mendes Jose , Jorge Escaleira Rui , Alves Gaspar Mariana , Malheiro Rui , Martins Diana , Silva-Nunes Jose

Introduction: Breast cancer is the second most common neoplasm in women. Hormonal replacement therapy and combined hormonal contraception are established extrinsic hormonal risk factors for breast cancer. Therefore, the increase in the prevalence of infertility and the use of assisted conception techniques have raised questions regarding the potential risk of hormone-dependent neoplasms. We report the case of a woman diagnosed with bilateral metastasized breast cancer soon aft...

ea0067gp26 | Poster Presentations | EYES2019

Multiple endocrine neoplasia type 1 presented with gastric neuroendocrine tumor: a case report

Lambrinoc Diana , Morea Alexandru , Burcea Iulia Florentina , Duşceac Roxana , Poiană Cătălina

Background: Multiple endocrine neoplasia type 1 (MEN1) is an inherited syndrome, characterized by primary MEN1 tumors: parathyroid, pancreatic and pituitary. We describe the case of a patient with MEN1 syndrome, initially presented with a gastric neuroendocrine tumor (NET).Case presentation: A 33-year-old male patient, initially treated for perforated gastric ulcer, presented 7 years later with dyspepsia, diarrhea and weight loss. Abdominal CT scan revea...

ea0063gp80 | Thyroid Autoimmune Disorders | ECE2019

Effect of nine months of vitamin D supplementation on muscle performance in Graves’ disease: a double-blinded, randomized clinical trial

Grove-Laugesen Diana , Malmstrom Sofie , Ebbehoj Eva , Riis Anne Lene , Watt Torquil , Hansen Klavs Wurgler , Rejnmark Lars

Background: Vitamin D deficiency has been proposed to play a role in development and course of Graves’ disease (GD). Muscle weakness and fatigue are shared features of GD and vitamin D deficiency. We aimed to investigate whether vitamin D supplementation would improve restoration of muscle performance and thyroid-related quality of life (QoL) in GD.Methods: In a double-blinded clinical trial, hyperthyroid patients with a first time diagnosis of GD w...

ea0063gp104 | Adrenal and Neuroendocrine - Basic | ECE2019

Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas

Yang Yuhong , Tetti Martina , Jaquin Diana , Mulatero Paolo , Schneider Holger , Beuschlein Felix , Reincke Martin , Williams Tracy Ann

Background: Aldosterone-producing adenomas (APA) are a major cause of primary aldosteronism. Somatic mutations explain the excess aldosterone production in the majority of patients with APA with mutations in the potassium channel KCNJ5 the most prevalent. In contrast, mechanisms driving cell proliferation are largely unresolved.Objective: To identify genes that modulate cell growth in APAs.Methods: Quantitative transcripto...

ea0063p713 | Pituitary and Neuroendocrinology 2 | ECE2019

Characterizing the microenvironment of pituitary neuroendocrine tumours, new approaches and tools to explore the function and contribution of folliculostellate cells

Ilie Mirela Diana , Chanal Marie , Principe Moitza , Gadot Nicolas , Vasiljevic Alexandre , Jouanneau Emmanuel , Raverot Gerald , Bertolino Philippe

Background: Tumour microenvironment (TME) can comprise >50% of the tumour mass and includes non-tumour cells like immune cells and fibroblasts, as well as extracellular matrix, signaling molecules, and blood and lymph vessels. In recent years, TME has begun to be considered both a prognostic tool and a therapeutic target. While the existence of TME is well accepted and described in numerous cancers, little is known about the TME of pituitary neuroendocrine tumours (PitNETs...

ea0063p795 | Thyroid 2 | ECE2019

Effect of vitamin D supplementation on cardiovascular indices in Graves’ disease. A randomized clinical trial

Grove-Laugesen Diana , Malmstroem Sofie , Ebbehoj Eva , Riis Anne Lene , Watt Torquil , Hansen Klavs Wurgler , Rejnmark Lars

Background: Risk of cardiovascular disease (CVD) and mortality is increased in Graves’ disease (GD) even years after initial diagnosis and treatment. The mechanisms are incompletely understood. Vitamin D insufficiency is associated with an increased risk of CVD and has been reported to occur frequently in GD. Pulse wave velocity (PWV) and blood pressure (BP) are important predictors of CVD. We performed a clinical trial, testing whether vitamin D supplementation affects P...